发明名称 PREVENTION AND TREATMENT OF CARDIOVASCULAR PATHOLOGIES WITH TAMOXIFEN ANALOGUES
摘要 A method for treating or preventing cardiovascular pathologies by administering a compound of formula (I), wherein Z is C=O or a covalent bond; Y is H or O(C1-C4)alkyl, R1 and R2 are individually (C1-C4)alkyl or together with N are a saturated heterocyclic group, R3 is ethyl or chloroethyl, R4 is H, R5 is I, O(C1-C4)alkyl or H and R6 is I, O(C1-C4)alkyl or H with the proviso that when R4, R5, and R6 are H, R3 is not ethyl; or a pharmaceutically acceptable salt thereof, effective to elevate the level of TGF-beta to treat and/or prevent conditions such as atherosclerosis, thrombosis, myocardial infarction, and stroke is provided. Useful compounds include idoxifene, toremifene or salts thereof. Further provided is a method for identifying an agent that elevates the level of TGF-beta. Another embodiment of the invention is an assay or kit to determine TGF-beta in vitro. Also provided is a therapeutic method comprising inhibiting smooth muscle cell proliferation associated with procedural vascular trauma employing the administration of tamoxifen or structural analogs thereof, including compounds of formula (I).
申请公布号 CA2223595(A1) 申请公布日期 1996.12.19
申请号 CA19962223595 申请日期 1996.06.07
申请人 NEORX CORPORATION;NEORX CORPORATION;NEORX CORPORATION;NEORX CORPORATION 发明人 METCALFE, JAMES C.;GRAINGER, DAVID J.;WEISSBERG, PETER L.;SCHROFF, ROBERT W.;KEMP, PAUL R.;KUNZ, LAWRENCE L..
分类号 G01N33/566;A61K31/135;A61K31/138;A61K31/38;A61K31/40;A61K31/445;A61P3/08;A61P7/02;A61P9/00;A61P9/08;A61P9/10;C07D295/08;G01N33/15;(IPC1-7):A61K31/135;A61M25/00;A61K31/395;G01N33/53 主分类号 G01N33/566
代理机构 代理人
主权项
地址